Aquestive Therapeutics Faces FDA Setback for Anaphylm Drug Approval
Aquestive Therapeutics stock plunges after FDA identifies deficiencies in Anaphylm application, a sublingual film treatment for severe allergic reactions.
NOTRELOAD AI
TD Cowen Upgrades Solar Stocks: SolarEdge & Array Technologies
TD Cowen upgrades SolarEdge and Array Technologies to Buy, citing strong execution, new products, and market growth opportunities.
Trump Meets Intel CEO to Discuss Chip Manufacturing Progress
President Trump and Intel CEO Lip-Bu Tan discussed the company's new processor line and government investment in American chip manufacturing at White House meeting.
Stifel Downgrades Intuitive Machines Ahead of Key NASA Decision
Stifel cuts Intuitive Machines to Hold as NASA’s lunar vehicle decision nears, citing political uncertainty and balanced risk-reward.
Citizens Upgrades Allogene Therapeutics to Outperform
Citizens upgraded Allogene Therapeutics to Outperform with a $5 target, citing improved trial visibility and strong long-term sales potential for cema-cel.
TD Cowen Starts Coverage on Constellation Energy with Buy Rating
TD Cowen initiates coverage of Constellation Energy with a Buy rating and a $440 price target, highlighting growth opportunities despite regulatory risks.